Hypoxia enhances the induction of human amniotic mesenchymal side population cells into vascular endothelial lineage

International Journal of Molecular Medicine

Volumn 32, Issue 2, 2013, Pages 315-322

  Maruyama, Naoko ^a   Kokubo, Kenichi ^a   Shinbo, Toshihiro ^a   Hirose, Minoru ^a   Kobayashi, Mamoru ^a   Sakuragawa, Norio ^a   Kobayashi, Hirosuke ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

Amniotic Mesenchymal Stem Cell; Hypoxia; Hypoxia Inducible Factor; Side Population; Vascular Endothelial Lineage

Indexed keywords

HYPOXIA INDUCIBLE FACTOR; VASCULAR CELL ADHESION MOLECULE 1; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN;

AMNION CELL; ANGIOGENESIS; ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CONTROLLED STUDY; DNA MICROARRAY; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOHISTOCHEMISTRY; MESENCHYME CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; SIDE POPULATION CELL; VASCULAR ENDOTHELIUM;

AMNION; ANOXIA; BIOLOGICAL MARKERS; CELL LINEAGE; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; MESENCHYMAL STROMAL CELLS; SIDE-POPULATION CELLS;

EID: 84879352764     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2013.1412     Document Type: Article

References (50)

1. Sakuragawa N, Yoshikawa H and Sasaki M: Amniotic tissue transplantation: Clinical and biochemical evaluations for some lysosomal storage diseases. Brain Dev 14: 7-11, 1992.
2. Wolbank S, Peterbauer A, Fahrner M, et al: Dose-dependent immunomodulatory effect of human stem cells from amniotic membrane: A comparison with human mesenchymal stem cells from adipose tissue. Tissue Eng 13: 1173-1183, 2007. (Pubitemid 46986718)
3. Hori J, Wang M, Kamiya K, Takahashi H and Sakuragawa N: Immunological characteristics of amniotic epithelium. Cornea 25 (Suppl 1): S53-S58, 2006.
4. Lefebvre S, Adrian F, Moreau P, et al: Modulation of HLA-G expression in human thymic and amniotic epithelial cells. Hum Immunol 61: 1095-1101, 2000. (Pubitemid 32043885)
5. Sakuragawa N, Kakinuma K, Kikuchi A, et al: Human amnion mesenchyme cells express phenotypes of neuroglial progenitor cells. J Neurosci Res 78: 208-214, 2004. (Pubitemid 39313793)
6. Konig JM, Huppertz B, Desoye G, et al: Amnion-derived mesenchymal stromal cells show angiogenic properties but resist differentiation into mature endothelial cells. Stem Cells Dev 21: 1309-1320, 2012.
7. Alviano F, Fossati V, Marchionni C, et al: Term amniotic membrane is a high throughput source for multipotent mesenchymal stem cells with the ability to differentiate into endothelial cells in vitro. BMC Dev Biol 7: 11, 2007.
8. Zhang P, Baxter J, Vinod K, Tulenko TN and Di Muzio PJ: Endothelial differentiation of amniotic fluid-derived stem cells: Synergism of biochemical and shear force stimuli. Stem Cells Dev 18: 1299-1308, 2009.
9. Ashton N, Ward B and Serpell G: Effect of oxygen on developing retinal vessels with particular reference to the problem of retrolental fibroplasia. Br J Ophthalmol 38: 397-432, 1954.
10. Knighton DR, Silver IA and Hunt TK: Regulation of wound-healing angiogenesis-effect of oxygen gradients and inspired oxygen concentration. Surgery 90: 262-270, 1981. (Pubitemid 11047238)
11. Knighton DR, Hunt TK, Scheuenstuhl H, Halliday BJ, Werb Z and Banda MJ: Oxygen tension regulates the expression of angiogenesis factor by macrophages. Science 221: 1283-1285, 1983. (Pubitemid 13001278)
12. Thomlinson RH and Gray LH: The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer 9: 539-549, 1955.
13. Folkman J, Merler E, Abernathy C and Williams G: Isolation of a tumor factor responsible for angiogenesis. J Exp Med 133: 275-288, 1971.
14. Liu Y, Cox SR, Morita T and Kourembanas S: Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5' enhancer. Circ Res 77: 638-643, 1995.
15. Forsythe JA, Jiang BH, Iyer NV, et al: Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16: 4604-4613, 1996. (Pubitemid 26272112)
16. Gerber HP, Condorelli F, Park J and Ferrara N: Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia. J Biol Chem 272: 23659-23667, 1997. (Pubitemid 27410939)
17. Waltenberger J, Mayr U, Pentz S and Hombach V: Functional upregulation of the vascular endothelial growth factor receptor KDR by hypoxia. Circulation 94: 1647-1654, 1996. (Pubitemid 26320271)
18. Goodell MA, Rosenzweig M, Kim H, et al: Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nat Med 3: 1337-1345, 1997. (Pubitemid 28011033)
19. Welm BE, Tepera SB, Venezia T, Graubert TA, Rosen JM and Goodell MA: Sca-1(pos) cells in the mouse mammary gland represent an enriched progenitor cell population. Dev Biol 245: 42-56, 2002. (Pubitemid 34461802)
20. Wulf GG, Luo KL, Jackson KA, Brenner MK and Goodell MA: Cells of the hepatic side population contribute to liver regeneration and can be replenished with bone marrow stem cells. Haematologica 88: 368-378, 2003. (Pubitemid 36547122)
21. Uchida N, Fujisaki T, Eaves AC and Eaves CJ: Transplantable hematopoietic stem cells in human fetal liver have a CD34(+) side population (SP)phenotype. J Clin Invest 108: 1071-1077, 2001. (Pubitemid 32946081)
22. Gussoni E, Soneoka Y, Strickland CD, et al: Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 401: 390-394, 1999. (Pubitemid 29454964)
23. Kobayashi M, Yakuwa T, Sasaki K, et al: Multilineage potential of side population cells from human amnion mesenchymal layer. Cell Transplant 17: 291-301, 2008. (Pubitemid 351717332)
24. Yamaguchi TP, Dumont DJ, Conlon RA, Breitman ML and Rossant J: Flk-1, an flt-related receptor tyrosine kinase is an early marker for endothelial cell precursors. Development 118: 489-498, 1993. (Pubitemid 23214035)
25. Shibuya M, Seetharam L, Ishii Y, et al: Possible involvement of VEGF-FLT tyrosine kinase receptor system in normal and tumor angiogenesis. Princess Takamatsu Symp 24: 162-170, 1994.
26. Lobb R, Chi-Rosso G, Leone D, et al: Expression and functional characterization of a soluble form of vascular cell adhesion molecule 1. Biochem Biophys Res Commun 178: 1498-1504, 1991.
27. Jones TR, Kao KJ, Pizzo SV and Bigner DD: Endothelial cell surface expression and binding of factor VIII/von Willebrand factor. Am J Pathol 103: 304-308, 1981. (Pubitemid 11112984)
28. Lampugnani MG, Resnati M, Raiteri M, et al: A novel endothelial-specific membrane protein is a marker of cell-cell contacts. J Cell Biol 118: 1511-1522, 1992.
29. Nichols J, Zevnik B, Anastassiadis K, et al: Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95: 379-391, 1998. (Pubitemid 28507326)
30. Niwa H, Miyazaki J and Smith AG: Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 24: 372-376, 2000. (Pubitemid 30187435)
31. Imamura M, Miura K, Iwabuchi K, et al: Transcriptional repression and DNA hypermethylation of a small set of ES cell marker genes in male germline stem cells. BMC Dev Biol 6: 34, 2006.
32. Chambers I, Colby D, Robertson M, et al: Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113: 643-655, 2003. (Pubitemid 36694189)
33. Mitsui K, Tokuzawa Y, Itoh H, et al: The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113: 631-642, 2003. (Pubitemid 36694188)
34. Levine AJ and Brivanlou AH: GDF3, a BMP inhibitor, regulates cell fate in stem cells and early embryos. Development 133: 209-216, 2006. (Pubitemid 43210710)
35. Li Y, McClintick J, Zhong L, Edenberg HJ, Yoder MC and Chan RJ: Murine embryonic stem cell differentiation is promoted by SOCS-3 and inhibited by the zinc finger transcription factor Klf4. Blood 105: 635-637, 2005. (Pubitemid 40070746)
36. Cartwright P, McLean C, Sheppard A, Rivett D, Jones K and Dalton S: LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism. Development 132: 885-896, 2005. (Pubitemid 40484924)
37. Avilion AA, Nicolis SK, Pevny LH, Perez L, Vivian N and Lovell-Badge R: Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev 17: 126-140, 2003. (Pubitemid 36062514)
38. Ben-Shushan E, Thompson JR, Gudas LJ and Bergman Y: Rex-1, a gene encoding a transcription factor expressed in the early embryo, is regulated via Oct-3/4 and Oct-6 binding to an octamer site and a novel protein, Rox-1, binding to an adjacent site. Mol Cell Biol 18: 1866-1878, 1998. (Pubitemid 28152635)
39. Yuan H, Corbi N, Basilico C and Dailey L: Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3. Genes Dev 9: 2635-2645, 1995.
40. Yang C, Przyborski S, Cooke MJ, et al: A key role for telomerase reverse transcriptase unit in modulating human embryonic stem cell proliferation, cell cycle dynamics, and in vitro differentiation. Stem Cells 26: 850-863, 2008.
41. Park D, Xiang AP, Mao FF, et al: Nestin is required for the proper self-renewal of neural stem cells. Stem Cells 28: 2162-2171, 2010.
42. Kaneko Y, Sakakibara S, Imai T, et al: Musashi1: An evolutio-nally conserved marker for CNS progenitor cells including neural stem cells. Dev Neurosci 22: 139-153, 2000. (Pubitemid 30098914)
43. Wang GL and Semenza GL: Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia. J Biol Chem 268: 21513-21518, 1993. (Pubitemid 23320639)
44. Semenza GL, Roth PH, Fang HM and Wang GL: Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem 269: 23757-23763, 1994. (Pubitemid 24293585)
45. Nguyen SV and Claycomb WC: Hypoxia regulates the expression of the adrenomedullin and HIF-1 genes in cultured HL-1 cardiomyocytes. Biochem Biophys Res Commun 265: 382-386, 1999.
46. Pescador N, Cuevas Y, Naranjo S, et al: Identification of a functional hypoxia-responsive element that regulates the expression of the egl nine homologue 3 (egln3/phd3) gene. Biochem J 390: 189-197, 2005. (Pubitemid 41192244)
47. Lennon DP, Edmison JM and Caplan AI: Cultivation of rat marrow-derived mesenchymal stem cells in reduced oxygen tension: Effects on in vitro and in vivo osteochondrogenesis. J Cell Physiol 187: 345-355, 2001. (Pubitemid 32378359)
48. Das R, Jahr H, van Osch GJ and Farrell E: The role of hypoxia in bone marrow-derived mesenchymal stem cells: Considerations for regenerative medicine approaches. Tissue Eng Part B Rev 16: 159-168, 2010.
49. Pugh CW and Ratcliffe PJ: Regulation of angiogenesis by hypoxia: Role of the HIF system. Nat Med 9: 677-684, 2003. (Pubitemid 36749216)
50. Szablowska-Gadomska I, Zayat V and Buzanska L: Influence of low oxygen tensions on expression of pluripotency genes in stem cells. Acta Neurobiol Exp 71: 86-93, 2011.